English 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
最新ニュース
住友商事、アクティスタイルを買収し米国で事業拡大へ
Sumitomo Corporation has fully acquired ActivStyle, LLC. This company is based in…
Veeva、ライフサイエンス向けAIエージェント「Veeva AI」を発表
Veeva Systems announced a major initiative called " Veeva AI ," which…
Nuclera社、APACおよび中東で販売網を拡大
Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop…
心筋症治療薬NuevocorがシリーズBでUS$45Mを調達
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant…
ジェネゼンとオプティウム、cGMP製造支援で提携
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and…
AGCバイオロジクス、抗体医薬品でノベルティ・ノビリティ社と提携
AGC Biologics, your friendly CDMO expert, announced a multiphase partnership with Novelty…
iRhythm、日本でZio心電図モニタリングサービスを開始
iRhythm Technologies, Inc. announced the commercial launch in Japan of its Zio long-term…
最新記事
日本語